Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Emergency Exit and Fire Drill Plan at Clinical Site – V 2.0

Posted on By

BA-BE Studies: SOP for Emergency Exit and Fire Drill Plan at Clinical Site – V 2.0

Standard Operating Procedure for Emergency Exit and Fire Drill Plan at Clinical Site in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/103/2025
Supersedes SOP/BA-BE/103/2022
Page No. Page 1 of 10
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the standard protocol for safe evacuation and conduct of fire drills at the clinical site conducting Bioavailability/Bioequivalence (BA/BE) studies, ensuring preparedness for emergencies and minimizing risks to volunteers and staff.

2. Scope

This SOP applies to all clinical staff, security personnel, facility engineers, and volunteers present at the clinical research unit during the execution of BA/BE studies.

3. Responsibilities

  • Safety Officer: Leads emergency preparedness programs and conducts fire drills.
  • Facility Engineer: Maintains emergency exits, fire extinguishers, alarms, and power backup systems.
  • Clinical Research Coordinator (CRC): Guides volunteers to safety during drills and real emergencies.
  • Principal Investigator (PI): Oversees overall safety strategy and ensures all staff are trained in evacuation procedures.
See also  BA-BE Studies: SOP for Labelling of Biological Samples - V 2.0

4. Accountability

The Head of Operations is accountable for ensuring the effectiveness of the emergency exit and fire drill plan, including infrastructure readiness and staff training.

5. Procedure

5.1 Emergency Exit Infrastructure

  1. Ensure emergency exit maps are displayed in all clinical areas and volunteer rooms (see Annexure-1).
  2. Emergency exits shall:
    • Remain unobstructed at all times
    • Be clearly illuminated with signage
    • Be accessible without keys or access cards

5.2 Fire Safety Equipment

  1. Equip the facility with:
    • Fire extinguishers (ABC type)
    • Smoke detectors and alarms
    • Sprinkler systems in high-risk areas
  2. Inspect equipment monthly and record in Annexure-2: Fire Safety Equipment Inspection Log.

5.3 Fire Drill Planning

  1. Conduct at least two full-scale fire drills per year.
  2. Drill must simulate realistic evacuation scenarios and involve:
    • Clinical and administrative staff
    • Volunteers (if present)
    • Security and emergency teams
  3. Document in Annexure-3: Fire Drill Execution Record.
See also  BA-BE Studies: SOP for Ethics Committee Submission Requirements - V 2.0

5.4 Actual Emergency Evacuation Procedure

  1. Upon fire alarm:
    • CRC and nurses escort volunteers toward designated exits
    • Security guides traffic to safe zones
    • PI or designee confirms area clearance
  2. Assemble at pre-identified muster point (see Annexure-4: Muster Point Attendance Log).
  3. Account for all staff and subjects immediately after evacuation.

5.5 Post-Drill/Incident Review

  1. Conduct debrief meeting with all teams.
  2. Prepare CAPA for gaps identified during the drill or actual emergency (Annexure-5).

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • CRC: Clinical Research Coordinator
  • CAPA: Corrective and Preventive Action
  • PI: Principal Investigator

7. Documents

  1. Emergency Exit Layout Map – Annexure-1
  2. Fire Safety Equipment Inspection Log – Annexure-2
  3. Fire Drill Execution Record – Annexure-3
  4. Muster Point Attendance Log – Annexure-4
  5. Fire Drill CAPA Form – Annexure-5

8. References

  • National Building Code of India
  • ICH E6(R2) – Good Clinical Practice
  • Local Fire Department Guidelines

See also  BA-BE Studies: SOP for Preparing for GCP Inspections and Audit Readiness - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Emergency Exit Layout Map

[Insert building plan with exits marked]

Annexure-2: Fire Safety Equipment Inspection Log

Date Location Equipment Status Inspected By
10/04/2025 Dosing Room ABC Extinguisher OK Ravi Nair

Annexure-3: Fire Drill Execution Record

Date Drill Start Time Evacuation Time No. of Staff No. of Subjects Remarks
15/03/2025 11:00 AM 5 min 18 12 Successful

Annexure-4: Muster Point Attendance Log

Name Role Present Signature
Sunita Reddy CRC Yes Signed

Annexure-5: Fire Drill CAPA Form

Observation Root Cause Corrective Action Preventive Action Owner
Exit blocked by cart Improper housekeeping Cart removed Monthly check protocol added Facility Head

Revision History:

Revision Date Revision No. Details Reason Approved By
10/01/2022 1.0 Initial SOP Site Setup QA Head
17/04/2025 2.0 Annexures and evacuation timing added Safety Enhancement QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Aerosol: SOP for Performance Qualification (PQ) of Aerosol Crimping Machines – V 2.0
Next Post: Creams: SOP for Accelerated Stability Testing of Cream Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version